Results for tag: "Alemtuzumab"

Alemtuzumab is a monoclonal antibody used to treat immune disorders, such as multiple sclerosis, chronic lymphocytic leukemia, and non-Hodgkin's lymphoma. It works by targeting and destroying certain types of white blood cells, which are responsible for the body's immune response. Alemtuzumab is administered intravenously and is usually given in two or three courses of treatment. Common side effects include fever, chills, nausea, and headache. Alemtuzumab is a relatively new drug, having been approved by the US Food and Drug Administration in 2014. It is used to treat a variety of immune disorders, and is often used in combination with other drugs. It is generally well-tolerated, and has been found to be effective in treating certain types of immune disorders. A number of companies are involved in the production and distribution of Alemtuzumab. These include Genzyme, Sanofi, Merck, and Pfizer. Additionally, a number of generic versions of the drug are available from various manufacturers. Show Less Read more